Prestige Brands Stands By Nix Lice 'Kill' Claims Despite NAD Rejection
This article was originally published in The Rose Sheet
Executive Summary
Prestige Brands declines to comply with NAD recommendations to discontinue “kill” claims for its Nix Ultra lice treatment product, arguing that “eliminating” lice infestation is tantamount to “killing” the bugs. In response, NAD refers the firm's ad claims to FTC.
You may also be interested in...
NAD Voice Muted In Deliberations On Appeals Of Its Decisions
The National Advertising Division changes its review process to allow opposing firms some control over scheduling in the process and in resolving their disputes. The changes, recommended by ABA committees, also impose fees for both firms in appeals and allow more time for compliance with decisions.
Lice Treatment Claims Require Tests On Humans, Not Just Bugs – NAD
NAD rejects TyraTech’s argument that because its Vamousse homeopathic works on lice and not people, non-human studies are adequate substantiation. Vamousse advertising referred to challenger Sanofi Pasteur’s Sklice prescription lice spray as less effective and more risky to human health.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.